81 related articles for article (PubMed ID: 14632194)
1. Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.
Gottumukkala RV; Waterman EA; Herd LM; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
J Invest Dermatol; 2003 Oct; 121(4):765-70. PubMed ID: 14632194
[TBL] [Abstract][Full Text] [Related]
2. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.
Kemp EH; Waterman EA; Hawes BE; O'Neill K; Gottumukkala RV; Gawkrodger DJ; Weetman AP; Watson PF
J Clin Invest; 2002 Apr; 109(7):923-30. PubMed ID: 11927619
[TBL] [Abstract][Full Text] [Related]
3. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies.
Gavalas NG; Gottumukkala RV; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
Exp Dermatol; 2009 May; 18(5):454-63. PubMed ID: 19320743
[TBL] [Abstract][Full Text] [Related]
4. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
5. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients.
Rahoma SF; Sandhu HK; McDonagh AJ; Gawkrodger DJ; Weetman AP; Kemp EH
Br J Dermatol; 2012 Jul; 167(1):17-28. PubMed ID: 22329856
[TBL] [Abstract][Full Text] [Related]
6. Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients.
Gottumukkala RV; Gavalas NG; Akhtar S; Metcalfe RA; Gawkrodger DJ; Haycock JW; Watson PF; Weetman AP; Kemp EH
Lab Invest; 2006 Aug; 86(8):781-9. PubMed ID: 16682974
[TBL] [Abstract][Full Text] [Related]
7. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
[TBL] [Abstract][Full Text] [Related]
8. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
[TBL] [Abstract][Full Text] [Related]
9. Melanin-concentrating hormone and melanin-concentrating hormone receptors in mammalian skin physiopathology.
Kemp EH; Weetman AP
Peptides; 2009 Nov; 30(11):2071-5. PubMed ID: 19442695
[TBL] [Abstract][Full Text] [Related]
10. Vitiligo autoantigen VIT75 is identified as lamin A in vitiligo by serological proteome analysis based on mass spectrometry.
Li Q; Lv Y; Li C; Yi X; Long HA; Qiao H; Lu T; Luan Q; Li K; Wang X; Wang G; Gao T
J Invest Dermatol; 2011 Mar; 131(3):727-34. PubMed ID: 21085190
[TBL] [Abstract][Full Text] [Related]
11. Identification of peptides specific for antibodies in vitiligo using a phage library.
Jadali Z; Eslami MB; Sanati MH; Mansouri P; Mahmoudi M; Maghsoudi N; Esfahanian F
Clin Exp Dermatol; 2005 Nov; 30(6):694-701. PubMed ID: 16197391
[TBL] [Abstract][Full Text] [Related]
12. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
Kroon MW; Kemp EH; Wind BS; Krebbers G; Bos JD; Gawkrodger DJ; Wolkerstorfer A; van der Veen JP; Luiten RM
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1172-5. PubMed ID: 22404127
[TBL] [Abstract][Full Text] [Related]
13. Interaction of neurochondrin with the melanin-concentrating hormone receptor 1 interferes with G protein-coupled signal transduction but not agonist-mediated internalization.
Francke F; Ward RJ; Jenkins L; Kellett E; Richter D; Milligan G; Bächner D
J Biol Chem; 2006 Oct; 281(43):32496-507. PubMed ID: 16945926
[TBL] [Abstract][Full Text] [Related]
14. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.
Kemp EH; Gawkrodger DJ; MacNeil S; Watson PF; Weetman AP
J Invest Dermatol; 1997 Jul; 109(1):69-73. PubMed ID: 9204957
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo.
Kemp EH; Emhemad S; Akhtar S; Watson PF; Gawkrodger DJ; Weetman AP
Exp Dermatol; 2011 Jan; 20(1):35-40. PubMed ID: 21158937
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1998 Dec; 114(3):333-8. PubMed ID: 9844040
[TBL] [Abstract][Full Text] [Related]
18. The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies.
Di Zenzo G; Calabresi V; Grosso F; Caproni M; Ruffelli M; Zambruno G
J Invest Dermatol; 2007 Apr; 127(4):864-73. PubMed ID: 17068480
[TBL] [Abstract][Full Text] [Related]
19. Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo.
Dorđić M; Matić IZ; Filipović-Lješković I; Džodić R; Sašić M; Erić-Nikolić A; Vuletić A; Kolundžija B; Damjanović A; Grozdanić N; Nikolić S; Pralica J; Dobrosavljević D; Rašković S; Andrejević S; Juranić Z
BMC Complement Altern Med; 2012 Jul; 12():109. PubMed ID: 22834951
[TBL] [Abstract][Full Text] [Related]
20. Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.
Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
J Invest Dermatol; 2010 Jan; 130(1):230-40. PubMed ID: 19587696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
